Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
University of Reading Featured PhD Programmes

ovarian cancer PhD Projects, Programmes & Scholarships

We have 16 ovarian cancer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 16 ovarian cancer PhD Projects, Programmes & Scholarships

PhD saved successfully

New anticancer therapies based on transition metal complexes

Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. Read more

Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer

One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. Read more

PhD position in genome stability and Cancer –Sept 2022

All organisms can suffer DNA double-strand breaks (DSBs), during meiosis, during DNA replication as elongating forks stall or collapse, or as a consequence of treatment with DNA damaging agents such as ionizing radiation. Read more

The role of splice variants in regulating BRCA1 function

Inheriting one mutant copy of the BReast CAncer 1 (BRCA1) gene (alongside one normal copy) is well-established as a strong risk factor for the development of breast and ovarian cancer. Read more

TARGETING MITOPHAGY TO REDUCE CHEMOTHERAPY-INDUCED PAIN

"Background. Chemotherapy-induced peripheral neuropathy (CIPN) is the most commonly reported side effect of chemotherapeutic drugs, affecting quality of life in many cancer patients. Read more

Genome Diversification in Cancer and Adaptive Immunity

Genomic instability (GI) is a hallmark of cancer that plays a central role in its initiation and development. GI can arise as a result of germline and somatic mutations that compromise a cell’s ability to accurately sense, signal or repair DNA damage. Read more

Genome Diversification in Cancer and Adaptive Immunity

Genomic instability (GI) is a hallmark of cancer that plays a central role in its initiation and development. GI can arise as a result of germline and somatic mutations that compromise a cell’s ability to accurately sense, signal or repair DNA damage. Read more

Institute of Chemical Biology (ICB) EPSRC Centre for Doctoral Training (CDT) in Chemical Biology: Innovation for the Life Sciences

Fully funded four-year studentships available for UK and International students. The Institute of Chemical Biology (ICB) Centre for Doctoral Training (CDT) is a postgraduate training programme, which forms the heart of the ICB at Imperial College London. Read more

Investigating the role of USP17 in intracellular trafficking

USP17 is over-expressed in a range of primary tumours including NSCLC, breast, colorectal, cervical, ovarian and osteosarcoma and its depletion has been shown to block the growth, and migration, of cells from all these cancer types. Read more

How does paclitaxel kill cells and why do some cells evade it?

Paclitaxel (Taxol) is a microtubule-stabilizing drug widely used for the treatment of breast, ovarian and lung cancers. For many years, it was thought to kill cancer cells by inducing mitotic arrest, thus preventing proliferation. Read more

Filtering Results